The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

the single-dose nasal spray is designed to be administered into one nostril, and was approved for use in adults and kids who weigh at least 66 pounds with severe allergies. Related: FDA approves ...

On 9 August, US health officials approved the first nasal spray to treat allergic ... of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and ...

Opens in a new tab or window The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ...

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

Last week the FDA approved Neffy, an epinephrine nasal spray, for use in emergency allergic reactions for kids and adults. Retired allergist at the Northwest Asthma & Allergy Center Paul Williams said ...

For the millions of Americans who have a food allergy, doctors recommend they always carry an epinephrine auto-injector, such ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

The US Food and Drug Administration (FDA) has approved the first nasal medicine to treat severe allergies. On 9 August, US health officials approved the first nasal spray to treat allergic ...